Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead
Author(s) -
Khalid Syed,
Tarun Saluja,
Heeyoun Cho,
Amber Hsiao,
Hanif Shaikh,
T. Anh Wartel,
Vittal Mogasale,
Julia Lynch,
Jérôme H. Kim,
JeanLouis Excler,
Sushant Sahastrabuddhe
Publication year - 2020
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa504
Subject(s) - typhoid fever , sanitation , salmonella typhi , medicine , typhoid vaccine , hygiene , environmental health , vaccination , transmission (telecommunications) , immunology , virology , biology , computer science , telecommunications , biochemistry , escherichia coli , pathology , gene
Control of Salmonella enterica serovar typhi (S. typhi), the agent of typhoid fever, continues to be a challenge in many low- and middle-income countries. The major transmission route of S. typhi is fecal-oral, through contaminated food and water; thus, the ultimate measures for typhoid fever prevention and control include the provision of safe water, improved sanitation, and hygiene. Considering the increasing evidence of the global burden of typhoid, particularly among young children, and the long-term horizon for sustained, effective water and sanitation improvements in low-income settings, a growing consensus is to emphasize preventive vaccination. This review provides an overview of the licensed typhoid vaccines and vaccine candidates under development, and the challenges ahead for introduction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom